世界の経皮吸収パッチ市場レポート：2017-2028年

出版：QYResearch（QYリサーチ）　出版年月：2022年12月

Global Transdermal Drug Patches Market Report, History and Forecast 2017-2028
世界の経皮吸収パッチ市場レポート：実績と予測　2017-2028年

レポート目次　　お問合せ・ご注文　　価格・納期について

Market Analysis and Insights: Global Transdermal Drug Patches Market
Due to the COVID-19 pandemic, the global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.
The global main manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, and IBSA Group, etc. In 2021, the global six largest players have a share approximately 41.80% in terms of revenue.
The North America Transdermal Drug Patches market size was US$ 3,340.28 million in 2021, while China was about US$ 288.23 million. The proportion of the China was 4.31% in 2021 and it is predicted that the share will reach 8.89% in 2028, trailing a CAGR of 12.34% through the analysis period.
Fully considering the economic change by the COVID-19, Methyl Salicylate-based Patch accounting for 13.17% of the Transdermal Drug Patches global market in 2021, is projected to value US$ 800.46 million by 2028, growing at a revised -0.91% CAGR from 2022 to 2028. While Rx Channel segment is altered to an 1.77% CAGR throughout this forecast period and will hold a share about 93.49% in 2028.
Global Transdermal Drug Patches Scope and Market Size
The global Transdermal Drug Patches market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segment by Application
Rx Channel
OTC Channel

By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories

By Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
SEA

Europe
Germany
France
U.K.
Italy
Spain

South America
Brazil
Argentina

Middle East & Africa
Saudi Arabia
UAE
Turkey
South Africa

目次

Tables and Figures

1 TRANSDERMAL DRUG PATCHES MARKET OVERVIEW 1
1.1 TRANSDERMAL DRUG PATCHES PRODUCT OVERVIEW 1
1.2 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY TYPE 4
1.2.1 METHYL SALICYLATE-BASED PATCH 4
1.2.2 RIVASTIGMINE TRANSDERMAL PATCH 4
1.2.3 FENTANYL TRANSDERMAL PATCH 5
1.2.4 LIDOCAINE PATCH 5
1.2.5 DICLOFENAC PATCH 6
1.2.6 NICOTINE TRANSDERMAL PATCH 6
1.3 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY TYPE 7
1.3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY TYPE (2017-2028) 8
1.3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022) 9
1.3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY TYPE (2023-2028) 11
1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE 12
1.4.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022) 12
1.4.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022) 14
1.4.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022) 16
1.4.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022) 18
1.4.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022) 20
2 TRANSDERMAL DRUG PATCHES MARKET COMPETITION BY COMPANY 23
2.1 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES SALES (2017-2022) 23
2.2 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES REVENUE (2017-2022) 25
2.3 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES PRICE (2017-2022) 28
2.4 GLOBAL TOP MANUFACTURERS TRANSDERMAL DRUG PATCHES MANUFACTURING BASE DISTRIBUTION, SALES AREA, PRODUCT TYPE 29
2.5 TRANSDERMAL DRUG PATCHES MARKET COMPETITIVE SITUATION AND TRENDS 30
2.5.1 TRANSDERMAL DRUG PATCHES MARKET CONCENTRATION RATE 30
2.5.2 GLOBAL 5 LARGEST MANUFACTURERS BY TRANSDERMAL DRUG PATCHES REVENUE IN 2021 30
2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN TRANSDERMAL DRUG PATCHES AS OF 2021) 31
2.7 KEY MANUFACTURERS TRANSDERMAL DRUG PATCHES PRODUCT OFFERED 32
2.8 MERGERS & ACQUISITIONS, EXPANSION 33
3 TRANSDERMAL DRUG PATCHES STATUS AND OUTLOOK BY REGION 34
3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE AND CAGR BY REGION: 2017 VS 2022 VS 2028 34
3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION 34
3.2.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022) 34
3.2.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022) 35
3.2.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022) 35
3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION 36
3.3.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028) 36
3.3.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028) 36
3.3.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028) 37
4 TRANSDERMAL DRUG PATCHES BY APPLICATION 38
4.1 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY APPLICATION 38
4.1.1 RX CHANNEL 38
4.1.2 OTC CHANNEL 39
4.2 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY APPLICATION 39
4.2.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028) 40
4.2.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022) 41
4.2.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 42
4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION 43
4.3.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022) 43
4.3.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022) 45
4.3.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022) 47
4.3.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022) 49
4.3.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022) 51
5 NORTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY 54
5.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY 54
5.1.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022) 54
5.1.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022) 54
5.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY 55
5.2.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028) 55
5.2.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028) 55
6 EUROPE TRANSDERMAL DRUG PATCHES BY COUNTRY 57
6.1 EUROPE TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY 57
6.1.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022) 57
6.1.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022) 57
6.2 EUROPE TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY 58
6.2.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028) 58
6.2.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028) 59
7 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES BY REGION 60
7.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION 60
7.1.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022) 60
7.1.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022) 60
7.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION 61
7.2.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028) 61
7.2.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028) 62
8 SOUTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY 63
8.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY 63
8.1.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022) 63
8.1.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022) 63
8.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY 64
8.2.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028) 64
8.2.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028) 64
9 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES BY COUNTRY 66
9.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY 66
9.1.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022) 66
9.1.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022) 66
9.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY 67
9.2.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028) 67
9.2.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028) 68
10 COMPANY PROFILES AND KEY FIGURES IN TRANSDERMAL DRUG PATCHES BUSINESS 69
10.1 HISAMITSU PHARMACEUTICAL 69
10.1.1 HISAMITSU PHARMACEUTICAL CORPORATION INFORMATION 69
10.1.2 HISAMITSU PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW 69
10.1.3 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 70
10.1.4 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 70
10.2 JOHNSON & JOHNSON 71
10.2.1 JOHNSON & JOHNSON CORPORATION INFORMATION 71
10.2.2 JOHNSON & JOHNSON INTRODUCTION AND BUSINESS OVERVIEW 72
10.2.3 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 72
10.2.4 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 73
10.3 MYLAN 74
10.3.1 MYLAN CORPORATION INFORMATION 74
10.3.2 MYLAN INTRODUCTION AND BUSINESS OVERVIEW 74
10.3.3 MYLAN TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 75
10.3.4 MYLAN TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 75
10.4 UCB PHARMA 76
10.4.1 UCB PHARMA CORPORATION INFORMATION 76
10.4.2 UCB PHARMA INTRODUCTION AND BUSINESS OVERVIEW 76
10.4.3 UCB PHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 77
10.4.4 UCB PHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 77
10.5 NOVARTIS 77
10.5.1 NOVARTIS CORPORATION INFORMATION 77
10.5.2 NOVARTIS INTRODUCTION AND BUSINESS OVERVIEW 78
10.5.3 NOVARTIS TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 78
10.5.4 NOVARTIS TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 79
10.6 TEVA PHARMACEUTICAL 79
10.6.1 TEVA PHARMACEUTICAL CORPORATION INFORMATION 79
10.6.2 TEVA PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW 80
10.6.3 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 81
10.6.4 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 81
10.7 BEIJING TIDE PHARMACEUTICAL 81
10.7.1 BEIJING TIDE PHARMACEUTICAL CORPORATION INFORMATION 81
10.7.2 BEIJING TIDE PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW 82
10.7.3 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 83
10.7.4 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 83
10.8 CHATTEM 84
10.8.1 CHATTEM CORPORATION INFORMATION 84
10.8.2 CHATTEM INTRODUCTION AND BUSINESS OVERVIEW 84
10.8.3 CHATTEM TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 85
10.8.4 CHATTEM TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 85
10.9 NITTO DENKO 85
10.9.1 NITTO DENKO CORPORATION INFORMATION 85
10.9.2 NITTO DENKO INTRODUCTION AND BUSINESS OVERVIEW 86
10.9.3 NITTO DENKO TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 86
10.9.4 NITTO DENKO TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 87
10.10 Grünenthal 87
10.10.1 Grünenthal CORPORATION INFORMATION 87
10.10.2 Grünenthal INTRODUCTION AND BUSINESS OVERVIEW 88
10.10.3 Grünenthal TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 88
10.10.4 Grünenthal TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 88
10.11 MUNDIPHARMA 89
10.11.1 MUNDIPHARMA CORPORATION INFORMATION 89
10.11.2 MUNDIPHARMA INTRODUCTION AND BUSINESS OVERVIEW 89
10.11.3 MUNDIPHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 90
10.11.4 MUNDIPHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 90
10.12 GSK 91
10.12.1 GSK CORPORATION INFORMATION 91
10.12.2 GSK INTRODUCTION AND BUSINESS OVERVIEW 92
10.12.3 GSK TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 92
10.12.4 GSK TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 92
10.13 LUYE PHARMA GROUP 93
10.13.1 LUYE PHARMA GROUP CORPORATION INFORMATION 93
10.13.2 LUYE PHARMA GROUP INTRODUCTION AND BUSINESS OVERVIEW 94
10.13.3 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 94
10.13.4 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 94
10.14 BAYER 95
10.14.1 BAYER CORPORATION INFORMATION 95
10.14.2 BAYER INTRODUCTION AND BUSINESS OVERVIEW 95
10.14.3 BAYER TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 96
10.14.4 BAYER TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 96
10.15 IBSA GROUP 97
10.15.1 IBSA GROUP CORPORATION INFORMATION 97
10.15.2 IBSA GROUP INTRODUCTION AND BUSINESS OVERVIEW 97
10.15.3 IBSA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 97
10.15.4 IBSA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 98
10.16 Dr Reddy’s Laboratories 98
10.16.1 Dr Reddy’s Laboratories CORPORATION INFORMATION 98
10.16.2 Dr Reddy’s Laboratories INTRODUCTION AND BUSINESS OVERVIEW 99
10.16.3 Dr Reddy’s Laboratories TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022) 99
10.16.4 Dr Reddy’s Laboratories TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED 100
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 101
11.1 TRANSDERMAL DRUG PATCHES KEY RAW MATERIALS 101
11.1.1 KEY RAW MATERIALS 101
11.1.2 RAW MATERIALS KEY SUPPLIERS 101
11.2 MANUFACTURING COST STRUCTURE 102
11.2.1 RAW MATERIALS 102
11.2.2 LABOR COST 102
11.2.3 MANUFACTURING EXPENSES 102
11.3 TRANSDERMAL DRUG PATCHES INDUSTRIAL CHAIN ANALYSIS 103
11.4 TRANSDERMAL DRUG PATCHES MARKET DYNAMICS 103
11.4.1 TRANSDERMAL DRUG PATCHES INDUSTRY TRENDS 103
11.4.2 TRANSDERMAL DRUG PATCHES MARKET DRIVERS 104
11.4.3 TRANSDERMAL DRUG PATCHES MARKET CHALLENGES 105
11.4.4 TRANSDERMAL DRUG PATCHES MARKET RESTRAINTS 105
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 107
12.1 SALES CHANNEL 107
12.2 TRANSDERMAL DRUG PATCHES DISTRIBUTORS 108
12.3 TRANSDERMAL DRUG PATCHES DOWNSTREAM CUSTOMERS 110
13 RESEARCH FINDINGS AND CONCLUSION 112
14 APPENDIX 113
14.1 RESEARCH METHODOLOGY 113
14.1.1 METHODOLOGY/RESEARCH APPROACH 113
14.1.2 DATA SOURCE 116
14.2 AUTHOR DETAILS 119
14.3 DISCLAIMER 119

Table 1. Global Transdermal Drug Patches Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) 8
Table 2. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces) 9
Table 3. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2017-2022) 9
Table 4. Global Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 10
Table 5. Global Transdermal Drug Patches Sales Market Share in Value by Type (2017-2022) 10
Table 6. Global Transdermal Drug Patches Price by Type (2017-2022) & (USD/Piece) 10
Table 7. Global Transdermal Drug Patches Sales by Type (2023-2028) & (M Pieces) 11
Table 8. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2023-2028) 11
Table 9. Global Transdermal Drug Patches Sales by Type (2023-2028) & (US$ Million) 11
Table 10. Global Transdermal Drug Patches Sales Market Share in Value by Type (2023-2028) 12
Table 11. Global Transdermal Drug Patches Price by Type (2023-2028) & (USD/Piece) 12
Table 12. North America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces) 12
Table 13. North America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 13
Table 14. Europe Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022) 14
Table 15. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 15
Table 16. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022) 16
Table 17. Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 17
Table 18. South America Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022) 18
Table 19. South America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 19
Table 20. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022) 20
Table 21. Middle East and Africa Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million) 21
Table 22. Global Transdermal Drug Patches Sales by Company (2017-2022) & (M Pieces) 23
Table 23. Global Transdermal Drug Patches Sales Share by Company (2017-2022) 24
Table 24. Global Transdermal Drug Patches Revenue by Company (2017-2022) & (US$ Million) 26
Table 25. Global Transdermal Drug Patches Revenue Share by Company (2017-2022) 26
Table 26. Global Market Transdermal Drug Patches Price by Company (2017-2022) & (USD/Piece) 29
Table 27. Global Transdermal Drug Patches Top Manufacturers Manufacturing Base Distribution and Sales Area 29
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2021) 31
Table 29. Key Manufacturers Transdermal Drug Patches Product Type 32
Table 30. Mergers & Acquisitions, Expansion Plans 33
Table 31. Global Transdermal Drug Patches Market Size Comparison by Region (US$ Million): 2017 VS 2022 VS 2028 34
Table 32. Global Transdermal Drug Patches Sales by Region (2017-2022) & (M Pieces) 34
Table 33. Global Transdermal Drug Patches Sales Market Share in Volume by Region (2017-2022) 34
Table 34. Global Transdermal Drug Patches Sales by Region (2017-2022) & (US$ Million) 35
Table 35. Global Transdermal Drug Patches Sales Market Share in Value by Region (2017-2022) 35
Table 36. Global Transdermal Drug Patches Sales (M Pieces), Value (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 35
Table 37. Global Transdermal Drug Patches Sales by Region (2023-2028) & (M Pieces) 36
Table 38. Global Transdermal Drug Patches Sales Market Share in Volume by Region (2023-2028) 36
Table 39. Global Transdermal Drug Patches Sales by Region (2023-2028) & (US$ Million) 36
Table 40. Global Transdermal Drug Patches Sales Market Share in Value by Region (2023-2028) 36
Table 41. Global Transdermal Drug Patches Sales (M Pieces), Value (US$ Million), Price (USD/Piece) and Gross Margin (2023-2028) 37
Table 42. Global Transdermal Drug Patches Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) 40
Table 43. Global Transdermal Drug Patches Sales by Application (2017-2022) & (M Pieces) 41
Table 44. Global Transdermal Drug Patches Sales Market Share in Volume by Application (2017-2022) 41
Table 45. Global Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 42
Table 46. Global Transdermal Drug Patches Sales Market Share in Value by Application (2017-2022) 42
Table 47. Global Transdermal Drug Patches Price by Application (2017-2022) & (USD/Piece) 42
Table 48. Global Transdermal Drug Patches Sales by Application (2023-2028) & (M Pieces) 42
Table 49. Global Transdermal Drug Patches Sales Market Share in Volume by Application (2023-2028) 42
Table 50. Global Transdermal Drug Patches Sales by Application (2023-2028) & (US$ Million) 43
Table 51. Global Transdermal Drug Patches Sales Market Share in Value by Application (2023-2028) 43
Table 52. Global Transdermal Drug Patches Price by Application (2023-2028) & (USD/Piece) 43
Table 53. North America Transdermal Drug Patches Sales by Application (2017-2022) & (M Pieces) 43
Table 54. North America Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 44
Table 55. Europe Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022) 45
Table 56. Europe Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 46
Table 57. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022) 47
Table 58. Asia-Pacific Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 48
Table 59. South America Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022) 49
Table 60. South America Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 50
Table 61. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Application (2017-2022) 51
Table 62. Middle East and Africa Transdermal Drug Patches Sales by Application (2017-2022) & (US$ Million) 52
Table 63. North America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces) 54
Table 64. North America Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022) 54
Table 65. North America Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million) 54
Table 66. North America Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022) 54
Table 67. North America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces) 55
Table 68. North America Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028) 55
Table 69. North America Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million) 55
Table 70. North America Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028) 55
Table 71. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces) 57
Table 72. Europe Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022) 57
Table 73. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million) 57
Table 74. Europe Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022) 58
Table 75. Europe Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces) 58
Table 76. Europe Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028) 58
Table 77. Europe Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million) 59
Table 78. Europe Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028) 59
Table 79. Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2022) & (M Pieces) 60
Table 80. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volumeby Region (2017-2022) 60
Table 81. Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2022) & (US$ Million) 60
Table 82. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Region (2017-2022) 61
Table 83. Asia-Pacific Transdermal Drug Patches Sales by Region (2023-2028) & (M Pieces) 61
Table 84. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Region (2023-2028) 61
Table 85. Asia-Pacific Transdermal Drug Patches Sales by Region (2023-2028) & (US$ Million) 62
Table 86. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Region (2023-2028) 62
Table 87. South America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces) 63
Table 88. South America Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022) 63
Table 89. South America Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million) 63
Table 90. South America Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022) 63
Table 91. South America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces) 64
Table 92. South America Transdermal Drug Patches Sales Market Share in Volume by Country (2023-2028) 64
Table 93. South America Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million) 64
Table 94. South America Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028) 64
Table 95. Middle East and Africa Transdermal Drug Patches Sales by Country (2017-2022) & (M Pieces) 66
Table 96. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Country (2017-2022) 66
Table 97. Middle East and Africa Transdermal Drug Patches Sales by Country (2017-2022) & (US$ Million) 66
Table 98. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Country (2017-2022) 67
Table 99. Middle East and Africa Transdermal Drug Patches Sales by Country (2023-2028) & (M Pieces) 67
Table 100. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2023-2028) 67
Table 101. Middle East and Africa Transdermal Drug Patches Sales by Country (2023-2028) & (US$ Million) 68
Table 102. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Country (2023-2028) 68
Table 103. Hisamitsu Pharmaceutical Corporation Information 69
Table 104. Hisamitsu Pharmaceutical Introduction and Business Overview 69
Table 105. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 70
Table 106. Hisamitsu Pharmaceutical Transdermal Drug Patches Product 70
Table 107. Johnson & Johnson Corporation Information 71
Table 108. Johnson & Johnson Introduction and Business Overview 72
Table 109. Johnson & Johnson Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 72
Table 110. Johnson & Johnson Transdermal Drug Patches Product 73
Table 111. Mylan Corporation Information 74
Table 112. Mylan Introduction and Business Overview 74
Table 113. Mylan Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 75
Table 114. Mylan Transdermal Drug Patches Product 75
Table 115. UCB Pharma Corporation Information 76
Table 116. UCB Pharma Introduction and Business Overview 76
Table 117. UCB Pharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 77
Table 118. UCB Pharma Transdermal Drug Patches Product 77
Table 119. Novartis Corporation Information 77
Table 120. Novartis Introduction and Business Overview 78
Table 121. Novartis Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 78
Table 122. Novartis Transdermal Drug Patches Product 79
Table 123. Teva Pharmaceutical Corporation Information 79
Table 124. Teva Pharmaceutical Introduction and Business Overview 80
Table 125. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 81
Table 126. Teva Pharmaceutical Transdermal Drug Patches Product 81
Table 127. Beijing Tide Pharmaceutical Corporation Information 81
Table 128. Beijing Tide Pharmaceutical Introduction and Business Overview 82
Table 129. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 83
Table 130. Beijing Tide Pharmaceutical Transdermal Drug Patches Product 83
Table 131. Chattem Corporation Information 84
Table 132. Chattem Introduction and Business Overview 84
Table 133. Chattem Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 85
Table 134. Chattem Transdermal Drug Patches Product 85
Table 135. Nitto Denko Corporation Information 85
Table 136. Nitto Denko Introduction and Business Overview 86
Table 137. Nitto Denko Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 86
Table 138. Nitto Denko Transdermal Drug Patches Product 87
Table 139. Gr眉nenthal Corporation Information 87
Table 140. Gr眉nenthal Introduction and Business Overview 88
Table 141. Gr眉nenthal Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 88
Table 142. Gr眉nenthal Transdermal Drug Patches Product 88
Table 143. Mundipharma Corporation Information 89
Table 144. Mundipharma Introduction and Business Overview 89
Table 145. Mundipharma Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 90
Table 146. Mundipharma Transdermal Drug Patches Product 90
Table 147. GSK Corporation Information 91
Table 148. GSK Introduction and Business Overview 92
Table 149. GSK Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 92
Table 150. GSK Transdermal Drug Patches Product 92
Table 151. Luye Pharma Group Corporation Information 93
Table 152. Luye Pharma Group Introduction and Business Overview 94
Table 153. Luye Pharma Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 94
Table 154. Luye Pharma Group Transdermal Drug Patches Product 94
Table 155. Bayer Corporation Information 95
Table 156. Bayer Introduction and Business Overview 95
Table 157. Bayer Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 96
Table 158. Bayer Transdermal Drug Patches Product 96
Table 159. IBSA Group Corporation Information 97
Table 160. IBSA Group Introduction and Business Overview 97
Table 161. IBSA Group Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 97
Table 162. IBSA Group Transdermal Drug Patches Product 98
Table 163. Dr Reddy檚 Laboratories Corporation Information 98
Table 164. Dr Reddy檚 Laboratories Introduction and Business Overview 99
Table 165. Dr Reddy檚 Laboratories Transdermal Drug Patches Sales (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022) 99
Table 166. Dr Reddy檚 Laboratories Transdermal Drug Patches Product 100
Table 167. Key Raw Materials Lists 101
Table 168. Raw Materials Key Suppliers Lists 101
Table 169. Transdermal Drug Patches Market Trends 103
Table 170. Transdermal Drug Patches Market Drivers 104
Table 171. Transdermal Drug Patches Market Challenges 105
Table 172. Transdermal Drug Patches Market Restraints 105
Table 173. Transdermal Drug Patches Distributors List 108
Table 174. Transdermal Drug Patches Downstream Customers 110
Table 175. Research Programs/Design for This Report 113
Table 176. Key Data Information from Secondary Sources 116
Table 177. Key Data Information from Primary Sources 118

List of Figures

Figure 1. Picture of Transdermal Patch 1
Figure 2. Global Transdermal Drug Patches Market Size, 2017 VS 2022 VS 2028 (US$ Million) 2
Figure 3. Global Transdermal Drug Patches Market Size Status and Outlook (2017-2028) & (US$ Million) 3
Figure 4. Global Transdermal Drug Patches Sales Status and Outlook (2017-2028) & (M Pieces) 3
Figure 5. Methyl Salicylate-based Patch Product Picture 4
Figure 6. Rivastigmine Transdermal Patch Product Picture 5
Figure 7. Fentanyl Transdermal Patch Product Picture 5
Figure 8. Lidocaine Patch Product Picture 6
Figure 9. Diclofenac Patch Product Picture 6
Figure 10. Nicotine Transdermal Patch Product Picture 7
Figure 11. Global Transdermal Drug Patches Sales by Type (2017-2028) & (US$ Million) 8
Figure 12. Global Transdermal Drug Patches Market Share by Type in 2022 & 2028 9
Figure 13. North America Transdermal Drug Patches Sales Market Share in Volume by Type in 2021 13
Figure 14. North America Transdermal Drug Patches Sales Market Share in Value by Type in 2021 14
Figure 15. Europe Transdermal Drug Patches Sales Market Share in Volume by Type in 2021 15
Figure 16. Europe Transdermal Drug Patches Sales Market Share in Value by Type in 2021 16
Figure 17. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Type in 2021 17
Figure 18. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Type in 2021 18
Figure 19. South America Transdermal Drug Patches Sales Market Share in Volume by Type in 2021 19
Figure 20. South America Transdermal Drug Patches Sales Market Share in Value by Type in 2021 20
Figure 21. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Type in 2021 21
Figure 22. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Type in 2021 22
Figure 23. Global Transdermal Drug Patches Sales Share by Company in 2021 25
Figure 24. Global Transdermal Drug Patches Revenue Share by Company in 2021 28
Figure 25. The 5 Largest Manufacturers in the World: Market Share by Transdermal Drug Patches Revenue in 2021 30
Figure 26. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 32
Figure 27. Rx Channel 38
Figure 28. OTC Channel 39
Figure 29. Global Transdermal Drug Patches Sales by Application (2017-2028) & (US$ Million) 40
Figure 30. Global Transdermal Drug Patches Market Share by Application in 2022 & 2028 41
Figure 31. North America Transdermal Drug Patches Sales Market Share in Volume by Application in 2021 44
Figure 32. North America Transdermal Drug Patches Sales Market Share in Value by Application in 2021 45
Figure 33. Europe Transdermal Drug Patches Sales Market Share in Volume by Application in 2021 46
Figure 34. Europe Transdermal Drug Patches Sales Market Share in Value by Application in 2021 47
Figure 35. Asia-Pacific Transdermal Drug Patches Sales Market Share in Volume by Application in 2021 48
Figure 36. Asia-Pacific Transdermal Drug Patches Sales Market Share in Value by Application in 2021 49
Figure 37. South America Transdermal Drug Patches Sales Market Share in Volume by Application in 2021 50
Figure 38. South America Transdermal Drug Patches Sales Market Share in Value by Application in 2021 51
Figure 39. Middle East and Africa Transdermal Drug Patches Sales Market Share in Volume by Application in 2021 52
Figure 40. Middle East and Africa Transdermal Drug Patches Sales Market Share in Value by Application in 2021 53
Figure 41. Transdermal Drug Patches Manufacturing Cost Structure 102
Figure 42. Transdermal Drug Patches Industrial Chain Analysis 103
Figure 43. Channels of Distribution 107
Figure 44. Distributors Profiles 109
Figure 45. Bottom-up and Top-down Approaches for This Report 115
Figure 46. Data Triangulation 116
Figure 47. Key Executives Interviewed 118